2018 Multidisciplinary Head and Neck Cancers Symposium

February 15-17, 2018
Scottsdale, Arizona

This is a practical and clinically relevant meeting for the entire head and neck cancer community that provides the most up-to-date information on multidisciplinary therapies, the latest clinical research, new treatment strategies, supportive care, scientific breakthroughs and toxicity mitigation.

Target Audience

This live activity is designed for medical oncologists, radiation oncologists, head and neck surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language scientists/pathologists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, physician scientists and rehabilitation specialists.

Learning Objectives

Upon completion of this live activity, attendees should be able to:

  • Explain the importance of multidisciplinary care in head and neck cancer and how to best apply it for optimal outcomes.
  • Describe key advances in immunotherapy in head and neck cancer.
  • Discuss recent advances in minimally invasive surgery in head and neck cancer and when to apply it in treating early and locally advanced disease.
  • Describe key advances in radiation therapy targeting and differences between various modalities.
  • Explain the recent changes in the staging system for head and neck cancer.
  • Discuss complex cases in head and neck cancer and how to best utilize current knowledge for decision-making.
  • Manage toxicities related to the management of head and neck cancer.
  • Summarize key recent advances in the understanding of the biology of head and neck cancer.  
Course summary
Available credit: 
  • 19.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 19.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 19.25 CAMPEP
    This activity has been approved for 19.25 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
  • 19.25 Certificate of Attendance
    This activity was designated for 19.25 AMA PRA Category 1 Credit™.
Course opens: 
12/21/2017
Course expires: 
02/15/2021
Cost:
$0.00
Rating: 
5

Physicians

The American Society for Radiation Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ASTRO designates this live activity for a maximum of 19.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicists

This activity has been approved for 19.25 Medical Physics Continuing Education Credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).

Physicist attendees will not receive certificates of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting.

Available Credit

  • 19.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 19.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 19.25 CAMPEP
    This activity has been approved for 19.25 medical physics continuing education credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
  • 19.25 Certificate of Attendance
    This activity was designated for 19.25 AMA PRA Category 1 Credit™.

Accreditation Period

Course opens: 
12/21/2017
Course expires: 
02/15/2021

Price

Cost:
$0.00
Please login or register to take this course.